Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (557)

  • Lobitz, S; Telfer, P; Cela, E; Allaf, B; Angastiniotis, M; Backman Johansson, C; Badens, C; Bento, C; Bouva, MJ; Canatan, D; Charlton, M; Coppinger, C; Daniel, Y; de Montalembert, M; Ducoroy, P; Dulin, E; Fingerhut, R; Frommel, C; Garcia-Morin, M; Gulbis, B; Holtkamp, U; Inusa, B; James, J; Kleanthous, M; Klein, J; Kunz, JB; Langabeer, L; Lapoumeroulie, C; Marcao, A; Soria, JLM; McMahon, C; Ohene-Frempong, K; Perini, JM; Piel, FB; Russo, G; Sainati, L; Schmugge, M; Streetly, A; Tshilolo, L; Turner, C; Venturelli, D; Vilarinho, L; Yahyaoui, R; Elion, J; Colombatti, R; European Reference Network.

    Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference

    BRITISH JOURNAL OF HAEMATOLOGY. 2018; 183(4): 648-660 Nº de citas: 101 [doi:10.1111/bjh.15600]

  • Canaani, J; Labopin, M; Huang, XJ; Ciceri, F; Van Lint, MT; Bruno, B; Santarone, S; Diez-Martin, JL; Blaise, D; Chiusolo, P; Wu, DP; Mohty, M; Nagler, A.

    Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

    BRITISH JOURNAL OF HAEMATOLOGY. 2018; 183(3): 411-420 Nº de citas: 26 [doi:10.1111/bjh.15540]

  • Rodriguez-Otero, P; Mateos, MV; Martinez-Lopez, J; Martin-Calvo, N; Hernandez, MT; Ocio, EM; Rosinol, L; Martinez, R; Teruel, AI; Gutierrez, NC; Bargay, J; Bengoechea, E; Gonzalez, Y; de Oteyza, JP; Gironella, M; Encinas, C; Martin, J; Cabrera, C; Palomera, L; de Arriba, F; Cedena, MT; Paiva, B; Puig, N; Oriol, A; Blade, J; Lahuerta, JJ; San Miguel, JF.

    Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

    LEUKEMIA. 2018; 32(11): 2427-2434 Nº de citas: 9 [doi:10.1038/s41375-018-0072-6]

  • Santos, N; Rodriguez-Romanos, R; de la Camara, R; Brunet, S; Nieto, JB; Buno, I; Martinez, C; Jimenez-Velasco, A; Vallejo, C; Gonzalez, M; Solano, C; Ferra, C; Sampol, A; Perez-Simon, JA; Lopez-Jimenez, J; Diez, JL; Gallardo, D.

    PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

    ANNALS OF HEMATOLOGY. 2018; 97(11): 2217-2224 Nº de citas: 10 [doi:10.1007/s00277-018-3438-y]

  • Osorio, S; Escudero-Vilaplana, V; Gomez-Centurion, I; Perez-Lopez, R; Ayala, R; Vall-Llovera, F; Garcia-Gutierrez, V; Casares, MTG; Miguel, JDGS; Hernandez-Rivas, JA; Sanchez-Guijo, F; Martinez-Garcia, AB; Villalon, L; Conesa-Garcia, V; Rodriguez, A; Casado, F; Garcia-Gonzalez, X; Perdomo, MNS; Banos, U; Steegmann, JL.

    Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

    ANNALS OF HEMATOLOGY. 2018; 97(11): 2089-2098 Nº de citas: 20 [doi:10.1007/s00277-018-3413-7]

  • Gayoso, J; Balsalobre, P; Kwon, M; Herrera, P; Bermudez, A; Sampol, A; Jimenez, S; Lopez-Corral, L; Serrano, D; Pinana, JL; Pascual, MJ; Heras, I; Bento, L; Varela, R; Humala, K; Zabalza, A; Laiglesia, A; Bastos-Oreiro, M; Perez-Corral, A; Martinez-Laperche, C; Buno, I; Diez-Martin, JL.

    Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes

    EUROPEAN JOURNAL OF HAEMATOLOGY. 2018; 101(3): 332-339 Nº de citas: 9 [doi:10.1111/ejh.13103]

  • Montalban, C; Diaz-Lopez, A; Martin, A; Baile, M; Sanchez, JM; Sancho, JM; Garcia, O; Novelli, S; Monter-Rovira, A; Salar, A; Bastos, M; Gutierrez, A; Bento, L; Corboda, R; Arquero, T; de Villambrosia, SG; Barranco, G; De Ona, R; Guillermo, AL; Salazar, MJR; Dominguez, JF; Fernandez, R; Queizan, JA; Rodriguez, J; Abraira, V; Garcia, JF.

    Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm

    BRITISH JOURNAL OF HAEMATOLOGY. 2018; 182(4): 534-541 Nº de citas: 6 [doi:10.1111/bjh.15446]

  • Suarez-Gonzalez, J; Martinez-Laperche, C; Martinez, N; Rodriguez-Macias, G; Kwon, M; Balsalobre, P; Carbonell, D; Chicano, M; Serrano, D; Trivino, JC; Piris, MA; Gayoso, J; Diez-Martin, JL; Buno, I.

    Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis

    LEUKEMIA. 2018; 32(8): 1822-1826 Nº de citas: 11 [doi:10.1038/s41375-018-0042-z]

  • Martinez-Laperche, C; Buces, E; Aguilera-Morillo, MC; Picornell, A; Gonzalez-Rivera, M; Lillo, R; Santos, N; Martin-Antonio, B; Guillem, V; Nieto, JB; Gonzalez, M; de la Camara, R; Brunet, S; Jimenez-Velasco, A; Espigado, I; Vallejo, C; Sampol, A; Bellon, JM; Serrano, D; Kwon, M; Gayoso, J; Balsalobre, P; Urbano-Izpizua, A; Solano, C; Gallardo, D; Diez-Martin, JL; Romo, J; Buno, I.

    A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

    Blood Advances. 2018; 2(14): 1719-1737 Nº de citas: 20 [doi:10.1182/bloodadvances.2017011502]

  • Suarez-Gonzalez, J; Martinez-Laperche, C; Kwon, M; Balsalobre, P; Carbonell, D; Chicano, M; Rodriguez-Macias, G; Serrano, D; Gayoso, J; Diez-Martin, JL; Buno, I.

    Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2018; 24(7): 1505-1513 Nº de citas: 25 [doi:10.1016/j.bbmt.2018.01.033]

  • Gonzalez-Vicent, M; Sanz, J; Fuster, JL; Cid, J; de Heredia, CD; Morillo, D; Fernandez, JM; Pascual, A; Badell, I; Serrano, D; Fox, L; de la Serna, J; Benito, A; Couselo, JM; Molina, B; Diaz, MA; Sanz, MA.

    Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Espanol De Trasplante de Medula Osea en Nimos (GETMON) and the Grupo Espanol de Trasplante Hematopoyetico (GETH)

    TRANSFUSION MEDICINE REVIEWS. 2018; 32(3): 179-185 Nº de citas: 26 [doi:10.1016/j.tmrv.2018.02.005]

  • Elosua-Gonzalez, M; Campos-Dominguez, M; Bancalari, D; Noguera-Morel, L; Hernandez-Martin, A; Huerta-Aragones, J; Torrelo, A.

    Omeprazole-induced hypertrichosis in two children

    PEDIATRIC DERMATOLOGY. 2018; 35(4): 212-214 Nº de citas: 5 [doi:10.1111/pde.13496]

  • Macias RIR; Sanchez-Martin A; Rodriguez-Macias G; Sanchez-Abarca LI; Lozano E; Herraez E; Odero MD; Diez-Martin JL; Marin JJG; Briz O.

    Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib.

    Oncotarget. 2018; 9(47): 28474-28485 Nº de citas: 12 [doi:10.18632/oncotarget.25494]

  • Font, P; Subira, D; Matarraz, S; Benavente, C; Cedena, MT; Morado, M; Corral, AP; Bellon, JM; Diez-Martin, JL.

    Multicenter comparison of CD34+myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2018; 94(3): 527-535 Nº de citas: 8 [doi:10.1002/cyto.b.21538]

  • Cesaro, S; Crocchiolo, R; Tridello, G; Knelange, N; Van Lint, MT; Koc, Y; Ciceri, F; Gulbas, Z; Tischer, J; Afanasyev, B; Bruno, B; Castagna, L; Blaise, D; Mohty, M; Irrera, G; Diez-Martin, JL; Pierelli, L; Pioltelli, P; Arat, M; Delia, M; Fagioli, F; Ehninger, G; Aljurf, M; Carella, AM; Ozdogu, H; Mikulska, M; Ljungman, P; Nagler, A; Styczynski, J.

    Comparable survival using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

    BONE MARROW TRANSPLANTATION. 2018; 53(4): 422-430 Nº de citas: 20 [doi:10.1038/s41409-017-0016-1]

  • Ruggeri, A; Labopin, M; Bacigalupo, A; Guelbas, Z; Koc, Y; Blaise, D; Bruno, B; Irrera, G; Tischer, J; Diez-Martin, JL; Castagna, L; Ciceri, F; Mohty, M; Nagler, A.

    Bone Marrow Versus Mobilized Peripheral Blood Stem Cells in Haploidentical Transplants Using Posttransplantation Cyclophosphamide

    CANCER. 2018; 124(7): 1428-1437 Nº de citas: 134 [doi:10.1002/cncr.31228]

  • Bazarbachi, A; Boumendil, A; Finel, H; Mohty, M; Castagna, L; Peggs, KS; Blaise, D; Afanasyev, B; Diez-Martin, JL; Sierra, J; Bloor, A; Martinez, C; Robinson, S; Malladi, R; El-Cheikh, J; Corradini, P; Montoto, S; Dreger, P; Sureda, A.

    Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party

    BRITISH JOURNAL OF HAEMATOLOGY. 2018; 181(1): 86-96 Nº de citas: 17 [doi:10.1111/bjh.15152]

  • Escudero-Vilaplana, V; Osorio-Prendes, S; Collado-Borrell, R; Gonzalez-Arias, E; Sanjurjo-Saez, M.

    Eosinophilia secondary to lenalidomide therapy

    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2018; 43(2): 273-275 Nº de citas: 3 [doi:10.1111/jcpt.12611]